Stewart-Brown S, Surender R, Bradlow J, Coulter A, Doll H
Department of Public Health and Primary Care, University of Oxford, Radcliffe Infirmary.
BMJ. 1995 Dec 9;311(7019):1543-7. doi: 10.1136/bmj.311.7019.1543.
To observe changes in prescribing practice that occurred after the introduction of fundholding in first wave practices and to contrast these with changes occurring in similar non-fundholding practices.
Prospective observational study.
Oxford region fundholding study.
Eight first wave fundholding practices and five practices that were not interested in fundholding in 1990-1, which were similar in terms of practice size, training status, locality, and urban rural mix. Three of the fundholding and none of the non-fundholding practices were dispensing practices.
Changes in prescribing practice as measured by net cost per prescribing unit, cost per item, number of items prescribed, and substitution rates for generic drugs three years after the introduction of fundholding. Data for fundholding practices were analysed separately according to whether they were dispensing or non-dispensing practices.
Prescribing costs rose by a third or more in all types of practice. The patterns of change observed in this cohort after one year of fundholding were reversed. No evidence existed that fundholding had controlled prescribing costs among non-dispensing fundholders; costs among dispensing fundholders rose least, but the differences were small compared with the overall increase in costs.
Early reports of the effectiveness of fundholding in curbing prescribing costs have not been confirmed in this longer term study.
观察首批实行基金持有制的医疗机构在引入该制度后处方行为的变化,并将这些变化与类似的非基金持有制医疗机构的变化进行对比。
前瞻性观察研究。
牛津地区基金持有制研究。
8家首批实行基金持有制的医疗机构以及5家在1990 - 1991年对基金持有制不感兴趣的医疗机构,这些机构在规模、培训状况、地理位置和城乡分布方面相似。其中3家实行基金持有制的医疗机构和0家非基金持有制医疗机构为配药机构。
在引入基金持有制三年后,以每个处方单位的净成本、每件药品的成本、所开药品数量以及通用药物的替换率来衡量处方行为的变化。实行基金持有制的医疗机构的数据根据其是否为配药机构进行单独分析。
所有类型的医疗机构处方成本均上涨了三分之一或更多。在实行基金持有制一年后观察到的变化模式发生了逆转。没有证据表明基金持有制在非配药的基金持有制医疗机构中控制了处方成本;配药的基金持有制医疗机构成本上涨最少,但与成本的总体增长相比,差异较小。
在这项长期研究中,早期关于基金持有制在控制处方成本方面有效性的报告未得到证实。